Loading clinical trials...
Loading clinical trials...
Chronic Effect of Daily Intake of SATIOSTAT Over 6 Weeks on Weight Loss, Glucose Tolerance, Gastrointestinal Tolerance and Gut Microbiota.
Conditions
Interventions
Control
SATIOSTAT
Locations
1
Switzerland
St Claraspital
Basel, Switzerland
Start Date
October 16, 2017
Primary Completion Date
May 6, 2019
Completion Date
May 6, 2019
Last Updated
August 14, 2019
NCT01143454
NCT07472881
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
University Hospital, Basel, Switzerland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions